We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma.
- Authors
Yamada, Hideharu; Takahashi, Masanobu; Watanuki, Munenori; Watanabe, Mika; Hiraide, Sakura; Saijo, Ken; Komine, Keigo; Ishioka, Chikashi
- Abstract
Oncol Lett 21: Article no. 455, 2021; DOI: 10.3892/ol.2021.12716 Subsequently to the publication of the above paper, the authors realized that the layouts of Tables I and III had been presented incorrectly, and that they had overlooking acknowledging researchers who had provided them with the cell lines in the Acknowledgements section of the paper.
- Subjects
LIPOSARCOMA; SARCOMA; LINCRNA; EPIDERMAL growth factor
- Publication
Oncology Letters, 2021, Vol 22, Issue 4, pN.PAG
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2021.12959